ultima actualización
18 de mayo del 2012

5.489.108 visitantes

Tratamiento de la miocardiopatia hipertrofica obstructiva (MOCH)

Bibliografìa

  1. Nishimura RA, Hayes DL, Ilstrup DM, Holmes DR, Tajil AJ: Effect of dual chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy: acute Doppler echocardiographic and catheterization hemodynamic study. J Am Coll Cardiol 27: 421, 1996.

  2. Fananapazir L, Cannon RO III, Tripodi D, Panza JA: Impact of dual chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blockers therapy. Circulation 85: 2149, 1992.

  3. Jeanrenaud X, Goy JJ, Kappenberg L: Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339: 1318, 1992.

  4. Tascón JC, Albarrán A, Alonso M y col: Respuesta hemodinámica inmediata a la estimulación bicameral en la miocardiopatía obstructiva severa. Rev Esp Cardiol 49: 815, 1996.

  5. Nishimura RA, Trusty JM, Hayes DL Y col: Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover study. J Am Coll Cardiol 29: 435, 1997.

  6. Fananapazir L, Epstein N, Curiel R, Panza J, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 90: 2731, 1994.

  7. Sadoul N, Simon JP, De Chillou C y col: Permanent cardiac pacing in hypertrophic and obstructive cardiomyopathy resistant to medical therapy. Arch Mal CÏur 87: 1315, 1994.

  8. De la Morena G, Martínez J, Castellón MI y col: Ventriculografía isotópica en pacientes con miocardiopatía obstructiva tratados con estimulación bicameral. Rev Esp Cardiol 51 (Suppl 1): 19, 1998.

  9. Pavin D, Gras D, De Palace G y col: Long-term effect of DDD pacing in patients with hypertrophic obstructive cardiomyopathy: is there a left ventricular remodelling? (Abstract). Pace 19: 680, 1996

  10. Fananapazir L, Epstein ND, Panza A, Curiel R, Tripodi D, McAreavey D: Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive syntomatic and hemodinamic improvement and reduction of left ventricular hypertrophy. Circulation 1994, 90:2731-2742.

  11. Nishimura RA, Hayes DL, Trusty JM: Dual chamber pacing for obstructive hypertrophic cardiomyopathy: a randomised, double-blind, crossover study. J Am Coll Cardiol 1997, 29:435-441.

  12. Maron BJ, Nishimura RA, Mc Kenna WJ, Rakowski H, Josephson ME, Kieval RS, Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy. A rondomized, double-blind, crossover study (M-PATHY). Circulation 1999, 99:2927-2933.

  13. Sigwart U, Grbie M, Essinger A, River JL: L´effet aigu dune occlusion coronarienne par ballonet de la dilatation transluminale (abstract). Schweiz Med Wochenschr 1982, 45:1631

  14. Heneinn MY, Kurbaan AS y col: Left ventricular diastolic function in HOCM after successful non-surgical septal reduction (Abstract). J Am Coll Cardiol 29 (suppl A): 388, 1997.

  15. Seggewib H, Faber L, Gleichmann U y col: Clinical and non-invasive follow-up results after percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy (Abstract). Eur Heart J 19 (suppl): 524, 1998.

  16. Lakkis NM, Killip D, Spencer WH III: Hypertrophic obstructive cardiomyopathy: Alternative therapeutic options. Clin Cardiol 1997, 20:417-418.

  17. Seggewiss H, Gleichmann U, Faber L et al. Ablacion transluminal percutanea del septo miocárdico en la miocardiopatia hipertrofica obstructiva: resultados agudos y seguimiento a los 3 meses en 25 pacientes. J Am Coll Cardiol 1998;31:252-258.

  18. Sigwart U. Nonsurgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-4.

  19. Knight C, Arvinder S, Kurbaan MB, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95: 2075-814-

  20. Gietzen F, Leuner CH, Raute-Kreinsen U et al. Acute and long-term results after transcoronary ablation of septum hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999; 20:1342-54.

  21. Gietzen F, Leuner CH, Gerenkamp T, Kuhn H. Relief of obstruction in hypertrophic cardiomyopathy by transient occlusion of the first septal branch of the left coronary artery (Abstr). Eur Heart J 1994; 15:125.

  22. Embolización distal de ramas septales con micropartículas para el tratamiento de la miocardiopatía hipertrófica obstructiva Autor: Djordje Pavlovic, José Suárez de Lezo, José Segura, Manuel Pan, Miguel Romero, Carmen Adamuz, Soledad Ojeda, Federico Vallés. Servicio de Cardiología. Hospital Universitario Reina Sofía. Córdoba

  23. Lakkis NM, Nagueh SF, Kleiman NS, Killip D, He Z-X, Verani MS, et al.: Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998, 98: 1750-1755.

  24. Kim JJ, Lee CW, Park SW, et al.: Improvement in exercise capacity an exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophy cardiomyopathy. Am J Cardiol. 1999, 83:1220-1223.

  25. Nagueh SF Lakkis NM, He Z-X, Killip D, Zoghbi WA, et al: Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1998, 32:225-229

  26. Nagueh SF Lakkis NM, Middleton KJ, et al.: Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999, 99:344-347.

  27. Faber L, Seggewiss H, Ziemssen P, et al.: Regression of left ventricular free wall hypertrophy nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy is independent of coexistent systematic arterial hypertension. J Am Coll Cardiol 1999, 33 (2, Suppl A):502A.

  28. Schulte HD, Bircks W, Losse B, Godehardt E, Schwartzkopff B. Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy. Late results up to twenty-five years. J Thorac Cardiovasc Surg 1993; 106:709-1 l.

  29. Theodoro D, Danielson G, Feldt R, Anderson B. Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg 1996; 112:1589-99.

  30. Morrow AG, Reitz BA, Epstein SE, et al. Operative treatment in hypertrophic subaortic stenosis: techniques, and the results of pre and postoperative assessments in 83 patients. Circulation 1975;52:88-102

  31. Maron BJ, Merrill WH, Freier PA, Kent KM, Epstein SE, Morrow AG. Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis. Circulation 1978;57:1205-1213.

  32. Williams WG, Wigle ED, Rakowski H, Smallhorn J, LeBlanc J, Trusler GA. Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation 1987;76:Suppl V:V-104.

  33. McIntosh CL, Maron BJ. Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 1988;78:487-495

  34. Cohn LH, Trehan H, Collins JJ Jr. Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 1992;70:657-660

  35. Ten Berg JM, Suttorp MJ, Knaepen PJ, Ernst SM, Vermeulen FE, Jaarsma W. Hypertrophic obstructive cardiomyopathy: initial results and long-term follow-up after Morrow septal myectomy. Circulation 1994;90:1781-1785

  36. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy: early and late results. J Thorac Cardiovasc Surg 1995;110:195-208

  37. Robbins RC, Stinson EB. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg 1996;111:586-594.

  38. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94:467-471

  39. Cooley DA, Leachman RD, Hallman GL, Gerami S, Hall RJ. Idiopathic hypertrophic subaortic stenosis: surgical treatment including mitral valve replacement. Arch Surg 1971;103:606-609.

  40. McIntosh CL, Greenberg GJ, Maron BJ, Leon MB, Cannon RO III, Clark RE. Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 1989;47:236-246.

  41. Mohr R, Schaff H, Danielson GK, The outcome of surgical treatment for obstructive hypertrophic cardiomyopathy: Experience over 15 years. J Thorac Cardiovasc Surg. 1998, 97:666-674.

Autor: Dr. Fernando Ordoñez

Ultima actualizacion: 22 de Mayo de 2003

© hemodinamiadelsur.com.ar es desarrollado y mantenido por ASAP Web | Consultoria de sistemas
Acuerdo con los usuarios
Get Adobe Reader Get Adobe Flash Player